1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with thiocholine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (thiocholine) | Trials (thiocholine) | Recent Studies (post-2010) (thiocholine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 180 | 0 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rainsford, KD | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thiocholine
| Article | Year |
|---|---|
Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arthritis; Arthritis, Experimental; Calcium; Cholinergic Agents; Female; Leukotriene Antagonists; Leukotriene B4; Male; Mice; Peptic Ulcer; Platelet Activating Factor; Rats; Thiocholine | 1999 |